Loading...
•
Dec 31, 2024
AirSculpt Q4 2024 Earnings Report
AirSculpt reported a decline in revenue and increased net loss in Q4 2024.
Key Takeaways
AirSculpt's Q4 2024 revenue declined by 17.7% YoY to $39.2 million, driven by lower case volume. The company reported a net loss of $5.0 million, widening from a $4.6 million loss a year ago. Adjusted EBITDA fell sharply to $1.9 million from $10.1 million in Q4 2023. Case volume dropped 16.7% YoY, and revenue per case decreased slightly to $12,787.
Revenue declined 17.7% YoY to $39.2 million.
Net loss widened to $5.0 million from $4.6 million in Q4 2023.
Adjusted EBITDA fell to $1.9 million from $10.1 million in Q4 2023.
Case volume declined 16.7% YoY to 3,064 cases.
AirSculpt
AirSculpt
Forward Guidance
AirSculpt expects ongoing challenges in Q1 2025 due to reduced marketing efforts at the end of 2024 but anticipates sequential improvements throughout the year as strategic initiatives take effect.
Positive Outlook
- Strategic focus on stabilizing same-center sales performance.
- Investment in data-driven marketing to improve customer acquisition.
- Expansion of financing options to make procedures more accessible.
- Cost reduction program expected to generate $3 million in savings.
- Improvements in lead generation as 2025 begins.
Challenges Ahead
- Revenue expected to remain under pressure due to macroeconomic factors.
- Same-center revenue expected to face a tough year-over-year comparison in Q1 2025.
- Lower marketing activity at the end of 2024 may impact near-term performance.
- Liquidity concerns with only $8.2 million in cash and no availability on revolving credit.
- Ongoing competitive pressure from weight-loss drugs and alternative procedures.